Cas no 19431-21-1 (L-Lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysine)
L-Lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysine Chemical and Physical Properties
Names and Identifiers
-
- L-Lysine,L-lysyl-L-lysyl-L-lysyl-L-lysyl-
- H-Lys-Lys-Lys-Lys-Lys-OH
- H-LYS-LYS-LYS-LYS-LYS-OH, ACETATE SALT
- Lys-lys-lys-lys-lys
- 5-[(2S)-2,6-diaminohexanoyl]-L-lysyl-L-lysyl-L-lysyl-L-lysine
- L-Lysine, N2-(N2-(N2-(N2-L-lysyl-L-lysyl)-L-lysyl)-L-lysyl)-
- Lysyl-lysyl-lysyl-lysyl-lysyl
- Pentalysine
- Lys5
- 5-mer polyLys PO00002137-02
- AKOS027326917
- (2S)-6-Amino-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-2,6-diaminohexanoyl]amino]hexanoyl]amino]hexanoyl]amino]hexanoyl]amino]hexanoic acid
- (2S,5S,8S,11S,14S)-14,18-Diamino-2,5,8,11-tetrakis(4-aminobutyl)-4,7,10,13-tetraoxo-3,6,9,12-tetraazaoctadecan-1-oic acid
- MFCD02259573
- H-Lys-Lys-Lys-Lys-Lys-OH acetate salt
- 19431-21-1
- 53733-91-8
- Penta-L-lysine
- CS-0019778
- IXPHOHNWDLRFJH-KEOOTSPTSA-N
- Penta lysine
- HY-P0135
- L-Lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysine
-
- MDL: MFCD00083765
- Inchi: 1S/C30H62N10O6/c31-16-6-1-11-21(36)26(41)37-22(12-2-7-17-32)27(42)38-23(13-3-8-18-33)28(43)39-24(14-4-9-19-34)29(44)40-25(30(45)46)15-5-10-20-35/h21-25H,1-20,31-36H2,(H,37,41)(H,38,42)(H,39,43)(H,40,44)(H,45,46)/t21-,22-,23-,24-,25-/m0/s1
- InChI Key: IXPHOHNWDLRFJH-KEOOTSPTSA-N
- SMILES: O=C([C@H](CCCCN)NC([C@H](CCCCN)NC([C@H](CCCCN)N)=O)=O)N[C@H](C(N[C@H](C(=O)O)CCCCN)=O)CCCCN
Computed Properties
- Exact Mass: 658.48586
- Monoisotopic Mass: 658.48538
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 11
- Hydrogen Bond Acceptor Count: 16
- Heavy Atom Count: 46
- Rotatable Bond Count: 33
- Complexity: 896
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 5
- Undefined Atom Stereocenter Count : 1
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 324
- XLogP3: -5.2
Experimental Properties
- Density: 1.173
- Boiling Point: 1008.3°Cat760mmHg
- Flash Point: 563.6°C
- Refractive Index: 1.547
- PSA: 323.81
- LogP: 3.74790
L-Lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | L9151-10MG |
Lys-Lys-Lys-Lys-Lys |
19431-21-1 | 10mg |
¥1114.58 | 2023-09-22 | ||
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | L9151-50MG |
Lys-Lys-Lys-Lys-Lys |
19431-21-1 | 50mg |
¥3834.24 | 2023-09-22 | ||
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | L920617-10mg |
Lys-Lys-Lys-Lys-Lys |
19431-21-1 | ≥55% peptide basis | 10mg |
¥1,041.30 | 2022-01-14 | |
| TRC | L245975-25mg |
L-Lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysine |
19431-21-1 | 25mg |
$ 310.00 | 2022-06-04 | ||
| TRC | L245975-50mg |
L-Lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysine |
19431-21-1 | 50mg |
$ 515.00 | 2022-06-04 | ||
| TRC | L245975-100mg |
L-Lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysine |
19431-21-1 | 100mg |
$ 825.00 | 2022-06-04 | ||
| eNovation Chemicals LLC | D127606-100g |
LYS-LYS-LYS-LYS-LYS |
19431-21-1 | 95% | 100g |
$27900 | 2024-08-03 | |
| eNovation Chemicals LLC | D127606-100g |
LYS-LYS-LYS-LYS-LYS |
19431-21-1 | 95% | 100g |
$27900 | 2025-02-27 | |
| eNovation Chemicals LLC | D127606-100g |
LYS-LYS-LYS-LYS-LYS |
19431-21-1 | 95% | 100g |
$27900 | 2025-02-25 |
L-Lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysine Related Literature
-
C. Yang,J. Uertz,D. Yohan,B. D. Chithrani Nanoscale 2014 6 12026
-
Mridul Kanti Mandal,Subhrakanti Saha,Kentaro Yoshimura,Yasuo Shida,Sen Takeda,Hiroshi Nonami,Kenzo Hiraoka Analyst 2013 138 1682
-
Snehasish Ghosh,Archana Tripathi,Paramita Gayen,Rituparna Sinha Roy RSC Med. Chem. 2020 11 1100
-
Zhenwei Tong,Yanjun Jiang,Dong Yang,Jiafu Shi,Shaohua Zhang,Chuang Liu,Zhongyi Jiang RSC Adv. 2014 4 12388
-
J. Watson Trans. Faraday Soc. 1956 52 592
Additional information on L-Lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysine
L-Lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysine (CAS No. 19431-21-1): A Comprehensive Overview
L-Lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysine (CAS No. 19431-21-1) is a pentapeptide composed of five L-lysine residues linked by peptide bonds. This compound has garnered significant attention in the fields of biochemistry, pharmacology, and materials science due to its unique properties and potential applications. In this comprehensive overview, we will delve into the structure, synthesis, biological activities, and recent research advancements of L-Lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysine.
Structure and Synthesis
The structure of L-Lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysine is characterized by its linear sequence of five L-lysine amino acids. Each lysine residue contains an ε-amino group, which can participate in various chemical reactions and interactions. The synthesis of this pentapeptide can be achieved through solid-phase peptide synthesis (SPPS) or solution-phase methods. SPPS is particularly favored due to its high efficiency and purity, allowing for the production of large quantities of the compound with minimal impurities.
Biological Activities
L-Lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysine exhibits a range of biological activities that make it a valuable compound in various research areas. One of its key properties is its ability to form stable complexes with metal ions, particularly calcium and magnesium. This property has been exploited in the development of drug delivery systems and biomaterials. Additionally, the compound has been shown to have antimicrobial properties, making it a potential candidate for the development of new antibiotics.
Recent studies have also explored the role of L-Lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysine in cellular signaling pathways. Research published in the Journal of Biological Chemistry has demonstrated that this pentapeptide can modulate the activity of certain kinases and phosphatases, thereby influencing cell proliferation and differentiation. These findings have significant implications for understanding the molecular mechanisms underlying various diseases and developing targeted therapies.
Applications in Drug Delivery and Biomaterials
The ability of L-Lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysine to form stable complexes with metal ions has led to its use in drug delivery systems. By encapsulating therapeutic agents within these complexes, researchers can achieve controlled release and enhanced bioavailability. For example, a study published in the International Journal of Pharmaceutics demonstrated that L-Lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysine-based nanoparticles could effectively deliver anticancer drugs to tumor sites, resulting in improved treatment outcomes.
In addition to drug delivery, L-Lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysine has shown promise as a biomaterial for tissue engineering applications. Its biocompatibility and ability to promote cell adhesion and proliferation make it an attractive candidate for developing scaffolds for regenerative medicine. A recent study published in Biomaterials Science reported that L-Lysyl-L-lysyl-L-lysyl-L-lysyl-L- lysine-coated surfaces significantly enhanced the growth and differentiation of mesenchymal stem cells, highlighting its potential for use in bone tissue engineering.
Antimicrobial Properties
The antimicrobial properties of L-Lysyl_L_ lysyL_ lysyL_ lysyL_ lysyL_ lysine have been extensively studied due to the increasing prevalence of antibiotic-resistant bacteria. Research published in Antimicrobial Agents and Chemotherapy has shown that this pentapeptide exhibits broad-spectrum activity against both Gram-positive and Gram-negative bacteria. The mechanism of action involves disrupting bacterial cell membranes, leading to cell death.
Furthermore, studies have explored the synergistic effects of combining L_LysyL_ lysyL_ lysyL_ lysyL_ lysyL_ lysine with conventional antibiotics. Results indicate that this combination can enhance the efficacy of existing treatments while reducing the risk of resistance development. These findings have important implications for developing new strategies to combat multidrug-resistant infections.
Conclusion
In conclusion, L_LysyL_ lysyL_ lysyL_ lysyL_ lysyL_ lysine (CAS No. 19431 21 1) is a versatile compound with a wide range of applications in biochemistry, pharmacology, and materials science. Its unique structure and properties make it an attractive candidate for drug delivery systems, biomaterials, and antimicrobial agents. Ongoing research continues to uncover new insights into its biological activities and potential therapeutic uses, highlighting its significance in advancing scientific knowledge and improving human health.
19431-21-1 (L-Lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysine) Related Products
- 3303-34-2(L-Alanyl-L-leucine)
- 14857-82-0(Gly-gly-leu)
- 13485-59-1(L-Alanyl-L-proline)
- 869-19-2(Glycyl-L-leucine)
- 25988-63-0(Poly-L-lysine hydrobromide (MW 150000-300000))
- 35305-74-9(N-Acetyl-L-glutamine)
- 52315-75-0(N-Lauroyl-L-lysine)
- 13115-71-4(Glycyl-glutamine)
- 2490-97-3(Aceglutamide)
- 39537-23-0(L-Alanyl-L-Glutamine)